Alzeimers disease

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/29

flashcard set

Earn XP

Description and Tags

Lecture 6

30 Terms

1
New cards

Is it common in clinics ? In general ? In our population ?

Will often see in clinic

Very common, increasingly rising in our population.

2
New cards

What is Alzheimers disease: Who discovered it ? When ? What is it ? (2) Prevalence ? Average survival from diagnosis ? Cure ?

  • Alois Alzheimer, 1907

  • Most common neurodegenerative disease

  • Progressive neurological disease which causes dementia

  • Prevalence increases with age– 7% of population between > 65 years– 15% of population > 75 years– 30% of population > 85 years

  • Average survival from diagnosis: 8-10 years

  • No cure


3
New cards
4
New cards

What are the stages of Alzeimers disease ?

Stage 1: no major impairment

Increased forgetfullness - also apparent in old age (they do not think they have a disease, more severe in stage 2.

Stage 2:

  • more severe memory loss, particularly for recent events

  • Storage of new memories imapired (short term memory is 1st affected)

  • errors in judgement / reasoning

  • Dysphagia / language difficulties

  • Restlessness (cannot sit still) / increased anxiety

  • Severe disorientation / confusion

  • Mood changes / depression / emotional instability

  • Psychosis / Hallucinations (later stage of stage 2)

  • Agression or docility

Stage 3:

  • All trace of presymtomatic personality lost

  • Mental emptiness

  • Loss of control of bodily functions

  • Severe debilitation, bed / wheelchair bound


5
New cards

Is Alzheimers a simple disease ? What does it affect ? (5)(5)(6)

Cognitive

  • Amnesia: memory formation

  • Aphasia - difficulty with language

  • Agnosia - difficulty identifying objects

  • Apraxia: problems with complex movements

  • Impaired executive functioning, reasoning (cannot have proper judgement and organising daily routines)

Behavioural

  • Depression

  • Agression

  • Apathy

  • Psychosis (some cases of this disease)

  • Psychomotor agitation

Functional

  • Social-Family Interaction

  • Independence

  • Maintaining hobbies

  • Driving

  • Handling Finances (need supervision)

  • Washing, Dressing, Eating


6
New cards

Alzeimers disease types: how many ? What are they called ? Which one is more common (%) ? What causes them ? What are they known as ?

  • ~ 95 % is Late-OnsetAlzheimer’s disease, usually starts in 7-9th decade, of unknown cause sometimes termed “sporadic” Reason for this is not known.

  • ~ 5% is Early OnsetAlzheimer’s disease can start at earlier age 4-5th decade due to inheritance of one faulty gene –in autosomal dominant fashion-termed “familial”


7
New cards

Alzeimers Disease Prevalence: How common is it ? What is _ ? Ageing ?

  • Alzheimers Disease is the most common dementia disorder

  • Dementia is a symptom, the main cause of which is AD

  • Dementia is NOT a normal part of ageing (impairement in cognition)


8
New cards

Dementia disorders ?

  • Alzheimers disease 60%

  • Vascular dementia (irregular blood supply of brain - causes memory impairement) 30%

  • Lew Body Dementia 10%

  • Frontotemporal Dementia 3%

  • Others - Picks Disease, Creutzfeldt - Jacob Disease, Parkinsons, Huntingtons (5%)


9
New cards

Prevalence of Dementia ? (3) Why is this happening ?

  • 46.8 million - 2015

  • 74.7 million - 2030

  • 131.5 million - 2050


10
New cards

Prevalance of Dementia (3) ? Age ?

  • 2015: 47.5 million cases of dementia worldwide

  • 2011: approx. 48,000 individuals in Ireland have dementia

  • Prevalance of dementia increases exponentially with age


11
New cards

What happens in the AD brain location ? steps ? At what level ?

The changing brain in Alzheimers disease at a macroscopic level.

In the brains of people with Alzheimers disease:

The cerebral cortex degenerates damaging areas involved in thinking, planning + remmebering

Degeneration is especially severe in the hippocampus an area of the cortex that plays a key role in formation of new memories

Ventricles: (fluid-filled spaces within the body) grow larger

12
New cards

Understanding brain degeneration in Alzheimer’s Disease

Molecular neuropathology -Investigating the composition and biology of plaques and tangles

13
New cards

Where are tangles and plaques found and what do they cause ?

  • Tangles: found inside the neuron, leads to cell death

  • Plaques: found outside neurons, induce cell death.


14
New cards

Pathology features (3)

1. Deposition of β-amyloid (Aβ) protein around neurons: neuritic plaques (amyloid plaques - induce cell death)

2. Presence of intracellular accumulation of tau protein: form neurofibrillary tangles (accumulate as disease progresses + causes further damage.

3. Activation of microglia (immune cells, release cytokines + neurotransmitters cause chronic inflammation) and inflammation

15
New cards

Investigating plaques ? How does it form ? Part of what ? What happens ? Consistency ? (5)

  • Plaques form when small protein pieces called B-amyloid clump together - more severe as the disease progresses

  • B amyloid is part of a ,cuh larger protein callled amyloid precursor protein (APP)

  • B-amyloid is cut out of APP by the action of 2 enzymes: B and y secretase

  • B amyloid is chemically “sticky” and gradually sticks together to form insoluable plaques at synapses + around nerves

  • mutations in these enzymes - accumulation of these amyloid plaques leads in the end to formation of these plaques.


16
New cards

Investigating tangles: What are they ? In healthy neruons ? In Alzeimers ? Eventually what will happen ?

  • Tangles are clumps of tau protein inside neurons

  • In healthy neruons, tau binds to and helps microtubles in axons, which are vital for neuron structure and function

  • In alzheimers, tau comes of the micritubles, moves into soma and dendrites - gains aberrant functions + sticks to itself forming paired filaments + insoluble clumps

  • Microtubule units in axons fall apart and distintegrate

  • Neurons with tangles eventually die


17
New cards

Stages in AD ? Linking ?

Stages of AD

Plaques + Tangles linked to disease symptoms

Stage 1: not much symptoms, memory impairement, hippocampus

  • Plaques and tangles appear in areas associated with memory, learning, thinking and planning

  • changes may begin 10 years or more before diagnosis

Stage 2:

  • Plaques and tangles spread to areas associated with speech, understanding, orientation (hippocampus - temporal area)

  • Generally lasts from 2-10 years

Stage 3: spread into main area of cortex + frontal cortex

  • Plaques and tangles are widespread in the cortex

  • Patients usually restricted to bed. Cannot form memories, orientation problems, need help eating, washing, dressing

  • Severe neuron loss occurs

  • May last from 1 to 5 years


18
New cards

What are we looking at now ?

Neurochemical approach –investigating whether Alzheimer’s is due to loss of selective neurotransmitter systems

19
New cards

What happens neurotransmitter systems in AD ?

There is changes

20
New cards

Neurotransmitter systems in Alzheimers disease (4)

  • 1976-80s - selective loss of markers of acetylcholine (most common system) were identified in Alzheimer’s disease

  • 1980s to present day - drug treatments for Alzheimer’s disease were developed to stop acetylcholine being degraded

  • 1980s to present day –realisation that acetylcholine is not the only neurotransmitter system affected in Alzheimer’s disease

  • Several neurotransmitter systems are affected including glutamate ( affects the excitatory neurotransmission), serotonin, noradrenaline


21
New cards

What was believed in former times and how was this proves wrong ?

  • Neurons in the hippocampus and cerebral cortex that produce acetlycholine degenerate:

  • Loss of cholinergic function correlates with cognitive and memory deficits

  • But system is outdates as we know that acetylcholine + other neurotransmitter systems are affected.


22
New cards

relationship ?

The relationship between: • Neuritic plaques • Neurofibrillary tangles • Cholinergic degeneration is not known

23
New cards

What are we looking at now ?

Molecular genetics– Identifying the genes that: cause the familial (inherited) forms of Alzheimer’s disease are linked to the idiopathic forms of Alzheimer’s disease

24
New cards

Molecular genetics of AD ?

  • 1991 – Mutations in the APP geneon chromosome 21 discovered to cause familial Alzheimer’s Disease: 1% of all familial Alzheimer’s cases & Down’s syndrome, trisomy 21, develop early onset AD (40’s), 75% of over 60 years DS have AD

  • 1995 - Mutations in Presenilin 1(PS 1) gene on chromosome 14 discovered to cause most cases of familial Alzheimer’s disease & 50-60% of all familial Alzheimer’s cases

  • 1998 - Mutations in taugene on chromosome 17 discovered to cause a dementia disorder (not Alzheimer’s disease)

  • 1993 – ApolipoproteinE(ApoE) e4 allele identified as a susceptibility risk gene for non-familial “sporadic” forms of Alzheimer’s

  • Research continues in these families


25
New cards

Diagnosis: (6) No what ?

  • Medical history

  • We have no biomarkers to diagnose

  • Interviews with family members: often patients ate so severely cognotively impaired

  • Memory tests: Mini-mental state exam MOCA (montreal cognitive Ax ) (spatial memory, long term memory, short term memory)

  • Absence of other neurological symptoms

  • Brain imaging: Magnetic reasonance imaging (MRI)

  • Computed tomography (CT) visualise plaques (only possible @ end stage)

  • Only certan at post-mortem


26
New cards

Treatment ?

  • No existing drugs to cue AD or stop progression

  • Currently used therapies to alleviate symptoms

  1. Cholinesterase inhibitors (increase amount of acetylcholine in synaptic cleft, Often given to patients in former times not very effective does not help memory)

  • Donepezil (Aricept) approved for all stages

  • Rivastigmine (Exelon) All stages

  • Galantamine (Reminyl, Galysa SR) mild - moderate

  1. Glutamate receptor antagonist

  • Memantine (Namenda) moderate - severe, does not restore full effect of memory


27
New cards

AD drug treatment: (4)

Acetylcholinesterase inhibitors– increases the synthesis of acetylcholine

Acetylcholine → → Choline + acetic acid , because of the enzyme Acetylcholinesterase

• Memantine– blocks the effect of high levels of glutamate

• Drugs for psychiatric and behavioural symptoms– Neuroleptics– Antidepressants

• (Other) – (Antioxidants e.g.. vitamin E)

28
New cards

Non drug treatment for AD ? (6)

  • OT

  • SLT

  • Assitive technology (walking aids, wheelchairs, prevent risk of falls)

  • Social support

  • Psychological therapies

  • Family support


29
New cards

what causes Alzheimers disease ? Risk factors (5) Modified risk factors (2) Lifetsyle (4) ? What has an important input on AD ?

For most patients, the cause of Alzheimer’s disease is unknown

Risk Factors

  • Age

  • Head trauma

  • Inflammation

  • Oxidative Stress

  • Susceptibility genes e.g. ApoE, APP, Presenilin

  • Modifiable Risk Factors

  • Cardiovascular /metabolic:

  • Mid-life hypertension / hypercholesterolemia / cardiovascular disease

  • Diabetes

  • Lifestyle:

  • Lack of exercise

  • Stress

  • Diet

  • Years of education


30
New cards

Prospects (3)

  • Earlier diagnosis

  • More effective therapies

  • Shift age of onset to the right